Document is current
Any future updates will be listed below
-
Authors
Figura, Nicholas B.
Rizk, Victoria T.
Armaghani, Avan J.
Arrington, John A.
Etame, Arnold B.
Han, Hyo S.
Czerniecki, Brian J.
Forsyth, Peter A.
Ahmed, Kamran A. https://orcid.org/0000-0003-3331-1529
- License Information
-
More Information
Article History
Received: 30 May 2019
Accepted: 7 June 2019
First Online: 17 June 2019
Compliance with ethical standards
:
: Nicholas B. Figura, Victoria T. Rizk, Avan J. Armaghani, John A. Arrington, Arnold B. Etame, and Brian J. Czerniecki declares that they have no conflict of interest. Hyo S. Han declares that she has received a speaker’s honorarium from Lilly Pharmaceuticals, research funding to the institution from Abbvie, Tesaro, TapImmune, Novartis, Bristol-Myers Squibb, Pfizer, SeattleGenetics, Prescient, Horizon, and Karyopharm. Peter A. Forsyth has received research funding from Pfizer and Celgene and is on the advisory boards of Novocure, BTG, Inovio, AbbVie, Ziopharm, Tocagen, and Pfizer; Kamran A. Ahmed has received research funding from Bristol-Myers Squibb and Genentech.
: This article does not contain any studies with human participants or animals performed by any of the authors.
